All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
J S Schneider, A Kean, L DiStefan. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice. Journal of neuroscience research. vol 42. issue 1. 1996-01-30. PMID:8531220. gm1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in mptp-treated mice. 1996-01-30 2023-08-12 mouse
J S Schneider, A Kean, L DiStefan. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice. Journal of neuroscience research. vol 42. issue 1. 1996-01-30. PMID:8531220. these results suggest that in addition to previously reported effects of gm1 on rescue and repair of dopaminergic neurons, gm1 may also have the ability to enhance dopamine synthesis in residual dopaminergic neurons. 1996-01-30 2023-08-12 mouse
M Bund, W Seitz, E Kirchne. [Is preventive perioperative dopamine administration of value?]. Anaesthesiologie und Reanimation. vol 20. issue 3. 1996-01-29. PMID:8526963. dopamine interacts in a dose dependent manner with three types of receptors: the alpha- and beta-adrenoceptors and specific dopaminergic receptors. 1996-01-29 2023-08-12 Not clear
S Shigetomi, Z O Yamada, H Ishii, H Sanada, H Watanabe, S Fukuch. Dopaminergic activity and endorenal dopamine synthesis in non-insulin dependent diabetes mellitus. Hypertension research : official journal of the Japanese Society of Hypertension. vol 18 Suppl 1. 1996-01-26. PMID:8529041. dopaminergic activity and endorenal dopamine synthesis in non-insulin dependent diabetes mellitus. 1996-01-26 2023-08-12 human
S Shigetomi, Z O Yamada, H Ishii, H Sanada, H Watanabe, S Fukuch. Dopaminergic activity and endorenal dopamine synthesis in non-insulin dependent diabetes mellitus. Hypertension research : official journal of the Japanese Society of Hypertension. vol 18 Suppl 1. 1996-01-26. PMID:8529041. from these results it is suggested that the relatively elevated peripheral dopaminergic activity and the blunted dopamine synthesis in the kidney may be responsible for the abnormal cardiovascular and renal responses to feeding in patients with niddm. 1996-01-26 2023-08-12 human
T Noshiro, H Akama, T Watanabe, T Kusakari, H Honma, S Shibukawa, W Miura, K Abe, Y Miur. Renal dopamine spillover rate using 3H-dopamine radiotracer technique as an index of renal dopaminergic nerve activity. Hypertension research : official journal of the Japanese Society of Hypertension. vol 18 Suppl 1. 1996-01-26. PMID:8529045. renal dopamine spillover rate using 3h-dopamine radiotracer technique as an index of renal dopaminergic nerve activity. 1996-01-26 2023-08-12 Not clear
T Ishiguro, K Shimamoto, T Sakamoto, M Hayashi, T Torii, O Iimur. Renal dopaminergic activity in patients with primary aldosteronism. Hypertension research : official journal of the Japanese Society of Hypertension. vol 18 Suppl 1. 1996-01-26. PMID:8529060. to clarify the role of renal dopaminergic activity in patients with primary aldosteronism (pa), urinary excretion of free dopamine (da) and the conversion ratio of da from l-dopa in the kidney were investigated in 8 patients with pa and 10 normotensive subjects (nt). 1996-01-26 2023-08-12 human
T Watanabe, T Noshiro, H Akama, T Kusakari, S Shibukawa, W Miura, K Abe, Y Miur. Effect of dexamethasone on plasma free dopamine: dopaminergic modulation in hypertensive patients. Hypertension research : official journal of the Japanese Society of Hypertension. vol 18 Suppl 1. 1996-01-26. PMID:8529061. effect of dexamethasone on plasma free dopamine: dopaminergic modulation in hypertensive patients. 1996-01-26 2023-08-12 human
T Watanabe, T Noshiro, H Akama, T Kusakari, S Shibukawa, W Miura, K Abe, Y Miur. Effect of dexamethasone on plasma free dopamine: dopaminergic modulation in hypertensive patients. Hypertension research : official journal of the Japanese Society of Hypertension. vol 18 Suppl 1. 1996-01-26. PMID:8529061. to investigate the peripheral dopaminergic modulation in the pathogenesis of human hypertension, we examined the responses of plasma free dopamine (da) to dexamethasone (dx) administration, which is suggested to activate dopaminergic activity. 1996-01-26 2023-08-12 human
H Ishii, S Shigetomi, S Niimura, H Sanada, S Fukuch. Postprandial changes in noradrenergic and dopaminergic activity in patients with essential hypertension. Hypertension research : official journal of the Japanese Society of Hypertension. vol 18 Suppl 1. 1996-01-26. PMID:8529062. the ratio of norepinephrine to dopamine following in eh was significantly greater than that in n. from these results, it is suggested that the feeding-induced stimulation of noradrenergic activity may be a result from the decrease in blood pressure, and that the blunted response of dopaminergic activity in eh may reflect the enhanced conversion of dopamine to norepinephrine probably due to the enhanced activity of dopamine beta-hydroxylase in the sympathetic nerves. 1996-01-26 2023-08-12 human
J Ichikawa, H Y Meltze. Effect of antidepressants on striatal and accumbens extracellular dopamine levels. European journal of pharmacology. vol 281. issue 3. 1996-01-25. PMID:8521908. further studies of the chronic effects of the selective serotonin reuptake inhibitor and the tricyclic antidepressants on dopaminergic activity are required to elucidate the role of dopamine in the antidepressant effect. 1996-01-25 2023-08-12 rat
C A Tieppo, A M Silva, J Palermo-Neto, A G Nasello, L F Felici. Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 28. issue 3. 1996-01-24. PMID:8520531. cholecystokinin (cck-8) coexists with dopamine in some neurons and modulates dopaminergic neurotransmission. 1996-01-24 2023-08-12 rat
M K Dahmer, S E Senogle. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors. Journal of neurochemistry. vol 66. issue 1. 1996-01-24. PMID:8522958. dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by d4 and d5 dopamine receptors. 1996-01-24 2023-08-12 Not clear
L Naudon, I Leroux-Nicollet, R Raisman-Vozari, D Botton, J Costenti. Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complex. Synapse (New York, N.Y.). vol 21. issue 1. 1996-01-19. PMID:8525459. early after treatment, a dramatic decrease in locomotor activity, as well as a marked depletion in striatal dopamine (da), associated with a prominent enhancement in dopaminergic turnover were observed in reserpine-treated rats. 1996-01-19 2023-08-12 rat
A Palumbo, M d'Ischia, G Misuraca, L De Martino, G Prot. Iron- and peroxide-dependent conjugation of dopamine with cysteine: oxidative routes to the novel brain metabolite 5-S-cysteinyldopamine. Biochimica et biophysica acta. vol 1245. issue 2. 1996-01-11. PMID:7492586. the mechanism of formation of 5-s-cysteinyldopamine (5-s-cda), a putative index of oxidative stress in dopaminergic regions of the brain, was investigated by comparing the ability of a number of neurochemically relevant oxidising systems to promote the conjugation of dopamine with cysteine in vitro. 1996-01-11 2023-08-12 Not clear
G Nisticó, M C Caroleo, M Arbitrio, L Pulvirent. Evidence for an involvement of dopamine D1 receptors in the limbic system in the control of immune mechanisms. Neuroimmunomodulation. vol 1. issue 3. 1996-01-04. PMID:7489331. the aim of the present study was to investigate the possible modulatory role played by specific dopamine d1 receptor subtypes within discrete sites of the brain dopaminergic pathways. 1996-01-04 2023-08-12 rat
X Wang, N Sato, M A Greer, P Falardea. Pituitary PRL secretion induced by tetraethylammonium is inhibited by dopamine through D2 receptors. Molecular and cellular endocrinology. vol 112. issue 2. 1996-01-04. PMID:7489818. the d2 dopaminergic receptor antagonist, sulpiride, at 10 microm reversed the inhibitory effect of 10 microm dopamine on prl secretion induced by 20 mm tea. 1996-01-04 2023-08-12 rat
A J Roberts, C N Lessov, T J Phillip. Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization. The Journal of pharmacology and experimental therapeutics. vol 275. issue 2. 1995-12-19. PMID:7473168. alteration of dopaminergic systems has been found in sensitized animals and dopamine neurotransmission appears to be crucial for the expression of sensitized behaviors. 1995-12-19 2023-08-12 mouse
A Heinz, H Przuntek, G Winterer, A Pietzcke. [Clinical aspects and follow-up of dopamine-induced psychoses in continuous dopaminergic therapy and their implications for the dopamine hypothesis of schizophrenic symptoms]. Der Nervenarzt. vol 66. issue 9. 1995-12-18. PMID:7477603. [clinical aspects and follow-up of dopamine-induced psychoses in continuous dopaminergic therapy and their implications for the dopamine hypothesis of schizophrenic symptoms]. 1995-12-18 2023-08-12 Not clear
M F Suaud-Chagny, C Dugast, K Chergui, M Msghina, F Gono. Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo. Journal of neurochemistry. vol 65. issue 6. 1995-12-15. PMID:7595557. the release of dopamine in the striatum, nucleus accumbens, and olfactory tubercle of anesthetized rats was evoked by electrical stimulation of the mesolimbic dopaminergic pathway (four pulses at 15 hz or four pulses at 200 hz). 1995-12-15 2023-08-12 rat